Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Aprameya EngineeringNSE:APRAMEYA 50 EV-to-FCF is 9.42 as of Jul. 13, 2026. GuruFocus rates NSE:APRAMEYA with a GF Score™ of 50/100. The stock has 6 warning signs investors should review. Among 416 Medical Devices & Instruments companies, Aprameya Engineering ranks better than 82.45% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Aprameya Engineering's Enterprise Value is ₹2,852.7 Mil.
Aprameya Engineering's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹302.7 Mil. Therefore, Aprameya Engineering's EV-to-FCF for today is 9.42.
The historical rank and industry rank for Aprameya Engineering's EV-to-FCF or its related term are showing as below:
NSE:APRAMEYA'
s EV-to-FCF Range Over the Past 10 Years
Min: -57.85 Med: -24.49 Max: 15.11
Current: 9.42
During the past 7 years, the highest EV-to-FCF of Aprameya Engineering was 15.11. The lowest was -57.85. And the median was -24.49.
NSE:APRAMEYA's EV-to-FCF is ranked better than 82.45% of 416
companies
in the Medical Devices & Instruments industry
Industry Median: 23.305
vs NSE:APRAMEYA: 9.42
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aprameya Engineering's PE Ratio (TTM) for today is calculated as:
Aprameya Engineering's share price for today is ₹146.15.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aprameya Engineering's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was ₹2.680.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aprameya Engineering EV-to-FCF Related Terms
Aprameya Engineering EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Aprameya Engineering's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:APRAMEYA vs ISRG, BDX, MDLN: EV-to-FCF Comparison
For the Medical Instruments & Supplies subindustry, Aprameya Engineering's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aprameya Engineering EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aprameya Engineering's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Aprameya Engineering's EV-to-FCF falls into.
Aprameya Engineering's current Enterprise Value is ₹2,852.7 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Aprameya Engineering's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was ₹302.7 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aprameya Engineering (NSE:APRAMEYA) has a EV-to-FCF of 9.42 as of Jul. 13, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aprameya Engineering and its competitors. According to the industry distribution chart, Aprameya Engineering ranks #73 out of 416 companies in the Medical Devices & Instruments industry, placing it in the top 17.5%.
Is Aprameya Engineering's EV-to-FCF too high?
Aprameya Engineering's current EV-to-FCF is 9.42. The Medical Devices & Instruments industry median EV-to-FCF is 23.31. Aprameya Engineering's value of 9.42 is 59.6% below this industry median. Based on the distribution chart, Aprameya Engineering ranks #73 out of 416 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Aprameya Engineering has a GF Score™ of 50/100, reflecting its overall financial health beyond just this single metric.
How does Aprameya Engineering's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Aprameya Engineering ranks #73 out of 416 companies for EV-to-FCF. This places Aprameya Engineering in the top 18% of its industry — outperforming the majority of peers. The industry median EV-to-FCF is 23.31. Aprameya Engineering's value of 9.42 is 59.6% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.31, based on 416 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aprameya Engineering's current EV-to-FCF of 9.42 is 59.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aprameya Engineering and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aprameya Engineering's current EV-to-FCF is 9.42. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aprameya Engineering stock overvalued right now?
Aprameya Engineering (NSE:APRAMEYA) has a current EV-to-FCF of 9.42. The current EV-to-FCF is 9.42 and 59.6% below the Medical Devices & Instruments industry median of 23.31. Aprameya Engineering's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Aprameya Engineering (NSE:APRAMEYA), the current EV-to-FCF is 9.42 as of Jul. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Aprameya Engineering Ltd is engaged in the business of installation, set up & maintenance of Intensive Care Units (ICU), Neonatal Intensive Care Units (NICU), Pediatric Intensive Care Units (PICU), Operation Theatre, dialysis centres and prefabricated structure ward (hereinafter referred to as Healthcare Infrastructure projects) in the hospitals and medical care centers on turnkey basis with the supply of high-value healthcare equipment and diagnostic equipment to private hospitals, Government hospitals, and medical practitioners. The company has two Business segments: Trading of Medical support Equipment (Trading Sales) and Supplies for Infra Projects for health care sectors (Turnkey project supplies). Key revenue is generated from Trunkey Project Supply.
50GF Score
Get the complete analysis for NSE:APRAMEYA
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:APRAMEYA has been successfully added to your 
